GlobeNewswire - Industry News on Health Care

Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition

Thu, 04 Feb 2021 21:30 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.?(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition. Sarepta has granted the winning authors $2,500 each and $2,500 to the educational institution with which each is affiliated. The winning submissions are now available on sharemylesson.com, and more information about the authors can be found at Sarepta.com/rarelessons.

Evaxion Biotech Announces Pricing of Initial Public Offering

Thu, 04 Feb 2021 21:16 GMT

COPENHAGEN, Denmark, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (“Evaxion”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, today announced the pricing of its initial public offering of 3,000,000 American Depositary Shares (“ADSs”), at a public offering price of $10 per ADS, with each such ADS representing one ordinary share, DKK 1 nominal value per share, of Evaxion (“Ordinary Shares”). The gross proceeds from the offering are expected to be approximately $30 million before deducting underwriting fees and commissions and other offering expenses. Evaxion has granted the underwriters an option for a period of 30 days from the date of the final prospectus to purchase an additional 450,000 ADSs at the initial public offering price.

CooperCompanies Announces Release Date for First Quarter 2021

Thu, 04 Feb 2021 21:15 GMT

SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.?? Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

Zealand Pharma to Host R&D Day on March 5, 2021

Thu, 04 Feb 2021 21:05 GMT

Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day

Thu, 04 Feb 2021 21:05 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on Thursday, February 11, 2021 at 3:30 p.m. ET. The fireside chat will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. Within 24 hours following the fireside chat, an archived replay of the webcast will be available for up to one year.

Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast

Thu, 04 Feb 2021 21:05 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its fourth quarter 2020 financial results and corporate update conference call and live audio webcast on?Thursday, February 11th?at 8:30 a.m. ET.

Prothena to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast Conference Call on February 11th

Thu, 04 Feb 2021 21:05 GMT

DUBLIN, Ireland, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, announced today that it will report its fourth quarter and full year 2020 financial results on Thursday, February 11, 2021 before the open of the U.S. financial markets. The announcement will be followed by a live audio conference call at 8:30 AM ET.

T2 Biosystems T2SARS-CoV-2? Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus

Thu, 04 Feb 2021 21:05 GMT

Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis

Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization

Thu, 04 Feb 2021 21:05 GMT

GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its pivotal Phase 3 trials in the United Kingdom (U.K.) and United States (U.S.) and through initial authorization for emergency use granted under country-specific regulations.

Berkeley Lights Announces CFO Transition and C-Level Additions

Thu, 04 Feb 2021 21:02 GMT

Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights

Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Thu, 04 Feb 2021 21:02 GMT

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation?(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021.

Misonix Reports Fiscal 2021 Second Quarter Financial Results

Thu, 04 Feb 2021 21:01 GMT

FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 second quarter ended December 31, 2020 as summarized below:

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results

Thu, 04 Feb 2021 21:01 GMT

Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth

Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Thu, 04 Feb 2021 21:01 GMT

CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 2:00 p.m. Eastern Time.

Itamar Medical Announces Proposed Offering of American Depositary Shares

Thu, 04 Feb 2021 21:01 GMT

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (“ADSs”) of the Company. Each ADS represents 30 ordinary shares of the Company. The ADSs to be sold in the offering will be offered by the Company and one of its shareholders, Viola Growth 2 A.V. Limited Partnership (the “Selling Shareholder”). The Company and the Selling Shareholder intend to grant to the underwriters a 30-day option to purchase up to an additional 15% of the ADSs being offered on the same terms and conditions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

IBA – ACQUISITION D’ACTIONS PROPRES

Thu, 04 Feb 2021 19:45 GMT

Publication immédiate – 4 février 2021

Iba – Acquisition of Own Shares

Thu, 04 Feb 2021 19:45 GMT

Access-Power & Co., Inc. is pleased to announce that the Company has completed all the required documentation with OTC Markets for a venue change consideration into the Pink Current Information tier

Thu, 04 Feb 2021 19:25 GMT

GRAND HAVEN, Mich., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce that it has completed all of?the required documentation with OTC Markets for a venue change consideration into the Pink Current Information tier.?Patrick J Jensen, our sole Director stated, “We must be clear with our Shareholders and Market Makers…this re-application process can take about 4 weeks or longer.”? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??

MultiBrush by Rendever Now Available on SideQuest, Providing Artists with a Collaborative Tool in Virtual Reality

Thu, 04 Feb 2021 18:30 GMT

Rendever’s CTO, Tom Neumann, was the first to develop a working multiplayer form of Tilt Brush, all in an effort to connect community members together

Rendever’s CTO, Tom Neumann, was the first to develop a working multiplayer form of Tilt Brush, all in an effort to connect community members together

PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings

Thu, 04 Feb 2021 18:01 GMT

RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:?PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25, 2021. The Company will also host a conference call on Friday, February 26, 2021 at 9:00 a.m. (ET) to discuss the results with members of the investment community.